查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1379098

分叉病变市场：2023-2028 年全球产业趋势、份额、规模、成长、机会与预测

Bifurcation Lesions Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3个工作天内

价格

抽象的

2022年，全球分叉病变市场规模达到23亿美元。展望未来， IMARC Group预计到2028年市场规模将达到31亿美元，2022-2028年复合年增长率（CAGR）为5.1%。

分叉病变是指邻近重要侧支（SB）起点的冠状动脉变窄。由于血流湍流和高剪切应力，容易形成动脉粥状硬化斑块。使用分析、手术持续时间、X 光照射和长期追踪等技术进行治疗。此外，三维（3D）血管摄影和多层电脑断层扫描用于测量分叉角。随着设备、影像、辅助药物治疗和血管通路的进步，全球复杂的分叉病变病例的治疗已成为可能。

分叉病变市场趋势：

冠状动脉疾病（CAD）发生率的显着增加增加了分叉病变的风险。这是推动市场成长的关键因素之一。除此之外，创新设备的批准、保险覆盖范围的扩大和成像方式的改进也正在加强市场的成长。此外，老年人口的增加（更有可能患上医疗疾病），以及各国政府为报销而采取的支持性倡议，正在支持市场的成长。医疗旅游业的成长、微创（MI）手术需求的不断增加以及医疗基础设施的改善是促进市场成长的其他因素。除此之外，正在进行的新型治疗技术研究正在推动市场发展。例如，研究人员正在研究 Szabo 2 支架技术对具有高危害风险或 SB 闭塞致命后果的复杂分叉病变的有效性。此外，对支架和球囊的广泛临床试验，加上熟练医疗保健专业人员数量的增加，预计将降低与分叉病变治疗相关的风险，并对市场产生积极影响。

本报告回答的关键问题

  • 2022年全球分叉病变市场规模有多大？
  • 2023-2028年全球分叉病变市场的预期成长率是多少？
  • COVID-19 对全球分叉病变市场有何影响？
  • 推动全球分叉病变市场的关键因素是什么？
  • 基于应用的全球分叉病变市场区隔如何？
  • 全球分叉病变市场的重点区域有哪些？
  • 全球分叉病变市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球分叉病变市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：按类型分類的市场细分

  • 一体式支架
    • 市场走向
    • 市场预测
  • 两支架
    • 市场走向
    • 市场预测

第 7 章：按应用分類的市场区隔

  • 冠状动脉
    • 市场走向
    • 市场预测
  • 周围血管
    • 市场走向
    • 市场预测

第 8 章：按地区分類的市场区隔

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 按国家/地区分類的市场细分
    • 市场预测

第 9 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 10 章：价值链分析

第 11 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 12 章：价格分析

第13章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Boston Scientific Corporation
    • Cardinal Health
    • Medtronic plc
    • Spectranetics (Koninklijke Philips NV)
    • Terumo Corporation
Product Code: SR112023A4003

Abstract

The global bifurcation lesions market size reached US$ 2.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.1 Billion by 2028, exhibiting a growth rate (CAGR) of 5.1% during 2022-2028.

A bifurcation lesion refers to the narrowing of the coronary artery adjacent to the origin of a significant side branch (SB). It is prone to develop atherosclerotic plaque due to turbulent blood flow and high shear stress. It is treated using techniques like analysis, procedure duration, X-ray exposure, and long-term follow-up. Moreover, three-dimensional (3D) angiography and multi-slice computed tomography are utilized for measuring the bifurcation angles. With the advances in devices, imaging, adjunctive pharmacotherapy, and vascular access, the management of complex cases of bifurcation lesions is becoming possible worldwide.

Bifurcation Lesions Market Trends:

A significant rise in the occurrence of coronary artery disease (CAD) is increasing the risk of developing bifurcation lesions. This represents one of the key factors bolstering the market growth. Besides this, the approval of innovative devices, increasing insurance coverage, and improving imaging modalities are also strengthening the market growth. Moreover, the rising geriatric population, which is more likely to develop medical ailments, along with supportive initiatives undertaken by governments of various countries for reimbursement, is supporting the market growth. The increasing medical tourism, the escalating demand for minimally invasive (MI) procedures and the improving healthcare infrastructure are some of the other factors contributing to the growth of the market. Apart from this, the ongoing research on novel treatment techniques is driving the market. For instance, researchers are studying the effectiveness of the Szabo 2-stent technique for complex bifurcations lesions with high compromise risk or fatal consequences of SB occlusion. Furthermore, a wide range of clinical trials on stents and balloons, in confluence with the increasing number of skilled healthcare professionals, is anticipated to decrease risks associated with bifurcation lesions treatment and influence the market positively.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global bifurcation lesions market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on types and application.

Breakup by Types:

One-Stent

Two-Stent

Breakup by Application:

Coronary Vascular

Peripheral Vascular

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Boston Scientific Corporation, Cardinal Health, Medtronic plc, Spectranetics (Koninklijke Philips N.V.) and Terumo Corporation.

Key Questions Answered in This Report

  • 1. What was the size of the global bifurcation lesions market in 2022?
  • 2. What is the expected growth rate of the global bifurcation lesions market during 2023-2028?
  • 3. What has been the impact of COVID-19 on the global bifurcation lesions market?
  • 4. What are the key factors driving the global bifurcation lesions market?
  • 5. What is the breakup of the global bifurcation lesions market based on the application?
  • 6. What are the key regions in the global bifurcation lesions market?
  • 7. Who are the key players/companies in the global bifurcation lesions market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Bifurcation Lesions Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Types

  • 6.1 One-Stent
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Two-Stent
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Coronary Vascular
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Peripheral Vascular
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Boston Scientific Corporation
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Cardinal Health
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Medtronic plc
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Spectranetics (Koninklijke Philips N.V.)
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 Terumo Corporation
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Bifurcation Lesions Market: Major Drivers and Challenges
  • Figure 2: Global: Bifurcation Lesions Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Bifurcation Lesions Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Bifurcation Lesions Market: Breakup by Types (in %), 2022
  • Figure 5: Global: Bifurcation Lesions Market: Breakup by Application (in %), 2022
  • Figure 6: Global: Bifurcation Lesions Market: Breakup by Region (in %), 2022
  • Figure 7: Global: Bifurcation Lesions (One-Stent) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 8: Global: Bifurcation Lesions (One-Stent) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 9: Global: Bifurcation Lesions (Two-Stent) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Bifurcation Lesions (Two-Stent) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Bifurcation Lesions (Coronary Vascular) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Bifurcation Lesions (Coronary Vascular) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Bifurcation Lesions (Peripheral Vascular) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Bifurcation Lesions (Peripheral Vascular) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: North America: Bifurcation Lesions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: North America: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: United States: Bifurcation Lesions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: United States: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Canada: Bifurcation Lesions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Canada: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Asia-Pacific: Bifurcation Lesions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Asia-Pacific: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: China: Bifurcation Lesions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: China: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Japan: Bifurcation Lesions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Japan: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: India: Bifurcation Lesions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: India: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: South Korea: Bifurcation Lesions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: South Korea: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Australia: Bifurcation Lesions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Australia: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Indonesia: Bifurcation Lesions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Indonesia: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Others: Bifurcation Lesions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Others: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Europe: Bifurcation Lesions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Europe: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Germany: Bifurcation Lesions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Germany: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: France: Bifurcation Lesions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: France: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: United Kingdom: Bifurcation Lesions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: United Kingdom: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Italy: Bifurcation Lesions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Italy: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Spain: Bifurcation Lesions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Spain: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Russia: Bifurcation Lesions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Russia: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Others: Bifurcation Lesions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Others: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Latin America: Bifurcation Lesions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Latin America: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Brazil: Bifurcation Lesions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Brazil: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Mexico: Bifurcation Lesions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Mexico: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Others: Bifurcation Lesions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Others: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Middle East and Africa: Bifurcation Lesions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Middle East and Africa: Bifurcation Lesions Market: Breakup by Country (in %), 2022
  • Figure 63: Middle East and Africa: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Global: Bifurcation Lesions Industry: SWOT Analysis
  • Figure 65: Global: Bifurcation Lesions Industry: Value Chain Analysis
  • Figure 66: Global: Bifurcation Lesions Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Bifurcation Lesions Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Bifurcation Lesions Market Forecast: Breakup by Types (in Million US$), 2023-2028
  • Table 3: Global: Bifurcation Lesions Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 4: Global: Bifurcation Lesions Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 5: Global: Bifurcation Lesions Market: Competitive Structure
  • Table 6: Global: Bifurcation Lesions Market: Key Players